| 12.99 -0.11 (-0.84%) | 04-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 16.37 | 1-year : | 17.23 |
| Resists | First : | 14.01 | Second : | 14.76 |
| Pivot price | 13.41 |
|||
| Supports | First : | 12.81 | Second : | 10.66 |
| MAs | MA(5) : | 13.19 |
MA(20) : | 13.55 |
| MA(100) : | 13.52  |
MA(250) : | 15.2 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 21.4 |
D(3) : | 24 |
| RSI | RSI(14): 42.5 |
|||
| 52-week | High : | 21.6 | Low : | 9.56 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OFIX ] has closed above bottom band by 28.5%. Bollinger Bands are 2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 13.29 - 13.38 | 13.38 - 13.45 |
| Low: | 12.76 - 12.85 | 12.85 - 12.92 |
| Close: | 12.86 - 13 | 13 - 13.12 |
Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Tue, 23 Apr 2024
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 - Business Wire
Tue, 23 Apr 2024
Orthofix Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 - Yahoo Finance Australia
Mon, 22 Apr 2024
Orthofix Medical (NASDAQ:OFIX) Given "Market Perform" Rating at JMP Securities - MarketBeat
Sat, 20 Apr 2024
Orthofix Medical (NASDAQ:OFIX) Share Price Crosses Above 200-Day Moving Average of $12.90 - MarketBeat
Tue, 16 Apr 2024
Orthofix Names Andres Cedron as New Chief Legal Officer - Business Wire
Thu, 07 Mar 2024
Orthofix Medical Inc (OFIX) Reports Significant Sales Growth and Improved EBITDA in Q4 and Full ... - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 37 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 3.4 (%) |
| Held by Institutions | 97.5 (%) |
| Shares Short | 3,840 (K) |
| Shares Short P.Month | 3,590 (K) |
| EPS | -4.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 16.11 |
| Profit Margin | -20.3 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | -6.4 % |
| Return on Equity (ttm) | -32.4 % |
| Qtrly Rev. Growth | 64 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 19.95 |
| EBITDA (p.s.) | -0.25 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -46 (M) |
| Levered Free Cash Flow | -118 (M) |
| PE Ratio | -3.16 |
| PEG Ratio | -3.1 |
| Price to Book value | 0.8 |
| Price to Sales | 0.65 |
| Price to Cash Flow | -10.63 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|